These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38532545)

  • 1. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
    Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
    Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival of nonlocalized epithelial ovarian cancer among women using menopausal hormone therapy prior to diagnosis: The extreme study.
    Baandrup L; Galanakis M; Hannibal CG; Dehlendorff C; Hertzum-Larsen R; Mørch LS; Kjaer SK
    Int J Cancer; 2022 Nov; 151(9):1512-1522. PubMed ID: 35716136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
    Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
    Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women: a Swedish population-based cohort study.
    Simin J; Liu Q; Wang X; Fall K; Williams C; Callens S; Engstrand L; Brusselaers N
    Acta Oncol; 2021 Jul; 60(7):881-887. PubMed ID: 33861686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of socioeconomic status on long-term survival of non-localized epithelial ovarian cancer ꟷ The Extreme study.
    Baandrup L; Dehlendorff C; Hertzum-Larsen R; Hannibal CG; Kjaer SK
    Gynecol Oncol; 2021 May; 161(2):458-462. PubMed ID: 33583579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival.
    Brieger KK; Peterson S; Lee AW; Mukherjee B; Bakulski KM; Alimujiang A; Anton-Culver H; Anglesio MS; Bandera EV; Berchuck A; Bowtell DDL; Chenevix-Trench G; Cho KR; Cramer DW; DeFazio A; Doherty JA; Fortner RT; Garsed DW; Gayther SA; Gentry-Maharaj A; Goode EL; Goodman MT; Harris HR; Høgdall E; Huntsman DG; Shen H; Jensen A; Johnatty SE; Jordan SJ; Kjaer SK; Kupryjanczyk J; Lambrechts D; McLean K; Menon U; Modugno F; Moysich K; Ness R; Ramus SJ; Richardson J; Risch H; Rossing MA; Trabert B; Wentzensen N; Ziogas A; Terry KL; Wu AH; Hanley GE; Pharoah P; Webb PM; Pike MC; Pearce CL;
    Gynecol Oncol; 2020 Sep; 158(3):702-709. PubMed ID: 32641237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.
    Hannibal CG; Kjaer SK; Galanakis M; Hertzum-Larsen R; Maltesen T; Baandrup L
    Gynecol Oncol; 2024 Mar; 182():1-6. PubMed ID: 38246041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone therapy treatment options and ovarian cancer risk: A Swedish prospective population-based matched-cohort study.
    Simin J; Tamimi RM; Callens S; Engstrand L; Brusselaers N
    Int J Cancer; 2020 Jul; 147(1):33-44. PubMed ID: 31584190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy and ovarian cancer.
    Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
    JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
    Greiser CM; Greiser EM; Dören M
    Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal hormone therapy and women's health: An umbrella review.
    Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
    PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
    DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
    J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of menopausal hormone therapy on the risk of ovarian cancer: Health Insurance Database in South Korea-based cohort study.
    Yuk JS; Kim M
    Menopause; 2023 May; 30(5):490-496. PubMed ID: 37022299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium.
    Petrick JL; Joslin CE; Johnson CE; Camacho TF; Peres LC; Bandera EV; Barnard ME; Beeghly A; Bethea TN; Dempsey LF; Guertin K; Harris HR; Moorman PG; Myers ER; Ochs-Balcom HM; Rosenow W; Setiawan VW; Wu AH; Schildkraut JM; Rosenberg L
    Br J Cancer; 2023 Dec; 129(12):1956-1967. PubMed ID: 37865688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal hormone therapy and risk of epithelial ovarian cancer.
    Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2548-56. PubMed ID: 18086757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hysterectomy and risk of epithelial ovarian cancer by histologic type, endometriosis, and menopausal hormone therapy.
    Ring LL; Baandrup L; Zheng G; Gottschau M; Dehlendorff C; Mellemkjær L; Kjaer SK
    Cancer Epidemiol; 2023 Jun; 84():102359. PubMed ID: 37054550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort.
    Brinton LA; Schwartz L; Spitz MR; Park Y; Hollenbeck AR; Gierach GL
    Cancer Causes Control; 2012 Mar; 23(3):487-96. PubMed ID: 22367699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.